
Melanoma Starts Evading Treatment Within Hours – Here’s How to Stop It
ISB researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.
ISB researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.
ISB’s Gibbons Lab developed a breakthrough method that analyzes food-derived DNA in fecal metagenomes, allowing for data-driven diet tracking without the need for burdensome questionnaires.
In a Research Roundtable presentation and Q&A, ISB President Dr. Jim Heath shared how his team is using generative AI to unlock new understanding of human immunity, and how these discoveries could help predict disease severity, improve cancer therapies, and more.
Just-published research out of ISB shows the microbial teamwork behind denitrification can collapse in polluted environments, threatening ecosystem balance and resilience.
In the May/June installment of the 2024-25 academic year roundup, we highlight recent funding news affecting the ISB Education team, as well as how our programs have affected students, teachers, and principals.
ISB Professor Sui Huang challenges the long-held belief that genetic mutations primarily drive cancer, offering a fresh perspective that could revolutionize how we think about and treat this complex disease.
Co-Author Craig Mundie and ISB’s Dr. Jim Heath discuss AI’s rapid evolution, ethical considerations, and potential to revolutionize science and society in a compelling Town Hall event.
ISB is deeply saddened to share the passing of Valerie Logan Hood, beloved wife of ISB Co-founder and Professor Dr. Lee Hood. Her lifelong dedication to K-12 education helped create and shape ISB’s programs, and her influence will be felt for generations to come.